Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients

Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients

Background Drug-induced proteinuria can occur in rheumatoid arthritis (RA) patients treated with d-penicillamine, gold salts, or bucillamine (Buc), and represents a drug hypersensitivity reaction. Striking associations of human leukocyte antigen (HLA) alleles with adverse reactions have recently bee...

Full description

Bibliographic Details
Main Authors:	Hiroshi Furukawa, Shomi Oka, Kota Shimada, Shoji Sugii, Atsushi Hashimoto, Akiko Komiya, Naoshi Fukui, Taiichiro Miyashita, Kiyoshi Migita, Akiko Suda, Shouhei Nagaoka, Naoyuki Tsuchiya, Shigeto Tohma
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-01-01
Series:	Biomarker Insights
Online Access:	https://doi.org/10.4137/BMI.S13654

Similar Items

HLA-DRB1*08:02 Is Associated with Bucillamine-Induced Proteinuria in Japanese Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2014-05-01)

Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients.
by: Hiroshi Furukawa, et al.
Published: (2013-01-01)

Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients.
by: Shomi Oka, et al.
Published: (2014-01-01)

Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope.
by: Hiroshi Furukawa, et al.
Published: (2012-01-01)

Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease
by: Hiroshi Furukawa, et al.
Published: (2019-08-01)

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations.
by: Hiroshi Furukawa, et al.
Published: (2018-01-01)

Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease
by: Shomi Oka, et al.
Published: (2022-06-01)

Associations of <i>HLA</i> Polymorphisms with Chronic Kidney Disease in Japanese Rheumatoid Arthritis Patients
by: Takashi Higuchi, et al.
Published: (2023-07-01)

Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight)
by: Hiroshi Furukawa, et al.
Published: (2015-04-01)

Role of Deleterious Rare Alleles for Acute-Onset Diffuse Interstitial Lung Disease in Collagen Diseases
by: Hiroshi Furukawa, et al.
Published: (2019-07-01)

Antibodies against Serum Anti-Melanoma Differentiation-Associated Gene 5 in Rheumatoid Arthritis Patients with Chronic Lung Diseases
by: Shomi Oka, et al.
Published: (2023-02-01)

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
by: Shomi Oka, et al.
Published: (2022-01-01)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
by: Hiroshi Furukawa, et al.
Published: (2015-08-01)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class l-Related Chain a (MICA) as Markers of ILD
by: Hiroshi Furukawa, et al.
Published: (2015-01-01)

Genetic risk factors for autoimmune hepatitis: implications for phenotypic heterogeneity and biomarkers for drug response
by: Takashi Higuchi, et al.
Published: (2021-01-01)

Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01.
by: Hiroshi Furukawa, et al.
Published: (2016-01-01)

Human leukocyte antigens and systemic lupus erythematosus: a protective role for the HLA-DR6 alleles DRB1*13:02 and *14:03.
by: Hiroshi Furukawa, et al.
Published: (2014-01-01)

A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition
by: Naoto Yokogawa, et al.
Published: (2020-05-01)

Association of a FAM13A variant with interstitial lung disease in Japanese rheumatoid arthritis
by: Hiroshi Furukawa, et al.
Published: (2023-01-01)

Lack of Association of rs12702634 in With Interstitial Lung Diseases in Japanese Rheumatoid Arthritis Patients
by: Takashi Higuchi, et al.
Published: (2022-04-01)

Human leucocyte antigens and Japanese patients with polymyalgia rheumatica: the protective effect of DRB1*09:01
by: Hiroshi Furukawa, et al.
Published: (2024-02-01)

The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica
by: Takashi Higuchi, et al.
Published: (2024-01-01)

Associations of <i>HLA</i> Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
by: Takashi Higuchi, et al.
Published: (2023-02-01)

Association of a Single Nucleotide Variant in <i>TERT</i> with Airway Disease in Japanese Rheumatoid Arthritis Patients
by: Takashi Higuchi, et al.
Published: (2023-11-01)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
by: Naoyuki Nishiya, et al.
Published: (2019-11-01)

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results
by: Shomi Oka, et al.
Published: (2022-03-01)

Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
by: Hiroshi Furukawa, et al.
Published: (2022-08-01)

Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.
by: Aya Kawasaki, et al.
Published: (2014-01-01)

POSTHERPETIC ORAL ULCERS MISDIAGNOSED AS PEMPHIGUS IN A PATIENT WITH RHEUMATOID ARTHRITIS UNDER BUCILLAMINE THERAPY
by: Toshiyuki Yamamoto
Published: (2013-11-01)

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)

A Case of Rheumatoid Arthritis with Bucillamine-Induced Yellow Nail Syndrome Initially Manifesting as Pulmonary Disease
by: Takeo Isozaki, et al.
Published: (2010-10-01)

Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan
by: Hiroshi Furukawa, et al.
Published: (2022-04-01)

Terahertz spectra of proteinuria and non-proteinuria
by: Zhenrui Xue, et al.
Published: (2023-02-01)

Proteinuria.
by: Haynes, J, et al.
Published: (2006)

Proteinúria
by: José V. Morales, et al.
Published: (2022-06-01)

The Association Between Metabolically Healthy Obesity and the Risk of Proteinuria: The Kansai Healthcare Study
by: Shinichiro Uehara, et al.
Published: (2018-08-01)

Roles of glomerular endothelial hyaluronan in the development of proteinuria
by: Akimasa Asai, et al.
Published: (2021-09-01)

Syphilis and Proteinuria in Pregnancy
by: Jay Jensen, et al.
Published: (2022-07-01)

IMUNOSSUPRESSÃO E PROTEINÚRIA
by: Andreia Fabiana do Vale Franco, et al.
Published: (2009-03-01)

Olmesartan in Management of Proteinuria
by: Satyanarayan Routray, et al.
Published: (2018-02-01)